You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

List of Excipients in API RESMETIROM


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing RESMETIROM

Company Tradename Ingredient NDC Excipient Potential Generic Entry
Madrigal Pharmaceuticals Inc REZDIFFRA resmetirom 82576-060 CELLULOSE, MICROCRYSTALLINE 2029-03-14
Madrigal Pharmaceuticals Inc REZDIFFRA resmetirom 82576-060 CROSCARMELLOSE SODIUM 2029-03-14
Madrigal Pharmaceuticals Inc REZDIFFRA resmetirom 82576-060 MAGNESIUM STEARATE 2029-03-14
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Detailed excipient profiles for RESMETIROM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: POLYETHYLENE GLYCOL 350

Excipient focus: SILICON DIOXIDE

Excipient focus: TALC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.